- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04419142
Total Fat Pad Excision Leads to Worse Isokinetic Performance in Total Knee Arthroplasty
Total Infrapatellar Fat Pad Excision Leads to Worse Isokinetic Performance in Total Knee Arthroplasty: A Randomized Controlled Trial
There are concerns that total infrapatellar fat pad (IPFP) excision in total knee arthroplasty (TKA) results in patellar tendon shortening due to ischemic contracture. But, individual preference of the surgeon is still the main determinant between total or partial excision. The aim of this randomized controlled trial is to compare knee society score (KSS), knee extension and flexion peak torque in patients undergoing TKA with total IPFP excision or partial IPFP excision. The hypothesis of the study is that during TKA, total IPFP excision would lead to worse isokinetic performance and clinical outcome.
A total of 72 patients scheduled to undergo TKA for primary osteoarthritis of the knee by a single surgeon were randomly assigned to either the total or partial excision group. Patients were evaluated preoperatively and at postoperative 1 year, with Knee Society Score (KSS) and isokinetic measurements. Physiatrist doing isokinetic tests and patients were blinded to the study.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aksaray, Turkey, 68200
- Aksaray University Training and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age between 55 and 80 years
- Scheduled to undergo unilateral TKA on for primary knee osteoarthritis
Exclusion Criteria:
- Inflammatory arthritis
- Post-traumatic osteoarthritis
- Previous knee surgery
- Neuromuscular diseases
- Bilateral TKA
- Insufficiency of collateral ligaments
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Total infrapatellar fat pad excision group
Infrapatellar fat pad was totally excised during total knee arthroplasty in patients randomized to this group.
|
Exposure for total knee arthroplasty (TKA) commonly includes total excision of the infrapatellar fat pad (IPFP).
The rationale behind this is to obtain improved access to the lateral tibial plateau allowing a more accurate bone cut, baseplate placement and easier management of soft tissue interposition in the bone and cement interface.
However, there is growing concern that as the IPFP is a highly vascularized and innervated fibrous adipose tissue filling the anterior compartment of the knee, its complete excision may have a detrimental effect on knee biomechanics and ultimately, TKA outcome.
The reason for this effect has been suggested to be patellar tendon (PT) scarring and shortening via ischemic contracture following impaired vascularization, maintenance and biological repair of the tendon.
|
Experimental: Partial infrapatellar fat pad excision group
Infrapatellar fat pad was partially excised during total knee arthroplasty in patients randomized to this group.
|
It has been suggested in the literature that partial infrapatellar fat pad excision instead of total excision would diminish the potential negative effect on patellar tendon and knee biomechanics.
However, there is only limited data in the literature and choice of total/partial infrapatellar fat pad excision in TKA remains debatable.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Peak knee extensor torque change from baseline to postoperative 12 months
Time Frame: Preoperative - Postoperative 12 months
|
Change in peak knee extensor torque from baseline (preoperatively) to 12 months post implantation was evaluated for the operated knee under the supervision of the same physiatrist.
The Isokinetic measurements were performed using a Biodex System III Isokinetic Dynamometer, version 3.03 (Biodex Medical Inc.,Shirley, NY, USA).
Concentric isokinetic knee flexion-extensions were assessed at a preset velocity of 60º/sec, over a range of motion of 0º to 110º for both parameters.
A fixed number of 10 flexion-extension repetitions was completed by each patient.
Torque was assessed in Newton-meters (N m).
|
Preoperative - Postoperative 12 months
|
Peak knee flexor torque change from baseline to postoperative 12 months
Time Frame: Preoperative - Postoperative 12 months
|
Change in peak knee flexor torque from baseline (preoperatively) to 12 months post implantation was evaluated for the operated knee under the supervision of the same physiatrist.
The Isokinetic measurements were performed using a Biodex System III Isokinetic Dynamometer, version 3.03 (Biodex Medical Inc.,Shirley, NY, USA).
Concentric isokinetic knee flexion-extensions were assessed at a preset velocity of 60º/sec, over a range of motion of 0º to 110º for both parameters.
A fixed number of 10 flexion-extension repetitions was completed by each patient.
Torque was assessed in Newton-meters (N m).
|
Preoperative - Postoperative 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Knee Society Score (KSS) change from baseline to postoperative 12 months
Time Frame: Preoperative - Postoperative 12 months
|
Change in the Knee Society Score from baseline (preoperatively) to 12 months post implantation was evaluated. The Knee Society Score (KSS) is comprised to two sections (each worth 100 points) for a maximum 200 points. One section is the Knee Society Clinical Score (KSCS) - points are given for pain, motion, and stability and points are deducted for flexion contracture, extension lag, and misalignment. The other section is the Knee Society Functional Score (KSFS) - points are assigned for walking distances and climbing stairs and points are deducted for use of walking aids. For each section, a score of 80-100 = excellent, 70-79 = good; 60-69 = fair; and < 60 = poor. |
Preoperative - Postoperative 12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Deniz Çankaya, MD, Aksaray University Training and Research Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1464/2017
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis, Knee
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
Tianjin XinChen-Techfields Pharma Co., LTD.Completed
-
Eun Jung KimMinistry of Health & Welfare, Korea; Semyung UniversityUnknownOsteoarthritis KneeKorea, Republic of
-
Thammasat UniversityCompletedPrimary Knee OsteoarthritisThailand
-
Galderma R&DCompletedUnilateral Knee OsteoarthritisUnited Kingdom
Clinical Trials on Total infrapatellar fat pad excision
-
Zhujiang HospitalThe First Affiliated Hospital of Anhui Medical University; Xiangya Hospital... and other collaboratorsRecruitingKnee Osteoarthritis | Arthropathy of KneeChina
-
NHS Greater Glasgow and ClydeRecruitingArthroplasty Complications | Knee DiscomfortUnited Kingdom
-
EMO Biomedicine CorporationFar Eastern Memorial HospitalCompleted
-
Liverpool University Hospitals NHS Foundation TrustCompleted
-
University Hospital Gregorio MarañónHospital del Río Hortega; Hospital de Leon; University of Navarrra Hospital (Clinica...RecruitingRectal Cancer | Sphincter Ani IncontinenceSpain
-
University of PittsburghCompleted
-
Ruijin HospitalWithdrawn
-
Sun Yat-sen UniversityCompleted
-
Yanhong DengCompleted
-
Mayo ClinicActive, not recruitingKnee Pain ChronicUnited States